• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Pancreatic Cancer, An Issue of Hematology/Oncology Clinics of North America

Pancreatic Cancer, An Issue of Hematology/Oncology Clinics of North America

9780323986557
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
544,26 zł
462,62 zł Zniżka 81,64 zł
Najniższa cena w okresie 30 dni przed promocją: 462,62 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis
In this issue of Hematology/Oncology Clinics, guest editors Drs. Matthew B. Yurgelun and Douglas A. Rubinson bring their considerable expertise to the topic of Pancreatic Cancer. Top experts in the field cover key topics such as pancreatic adenocarcinoma:: trends in epidemiology, risk factors, and outcomes; decision making regarding perioperative therapy in individuals with localized pancreatic adenocarcinoma; the evolving role of radiotherapy in the management of individuals with pancreatic adenocarcinoma; and more.
Szczegóły produktu
Elsevier
94144
9780323986557
9780323986557

Opis

Rok wydania
2022
Numer wydania
1
Oprawa
twarda
Liczba stron
240
Waga (g)
450
  • Pancreatic Adenocarcinoma: Trends in Epidemiology, Risk Factors, and Outcomes
    The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes
    What Can We Learn About Pancreatic Adenocarcinoma from Imaging?
    Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals
    Germline Testing for Individuals with Pancreatic Adenocarcinoma and Novel Genetic Risk Factors
    Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma
    Novel Considerations in Surgical Management of Individuals with Pancreatic Adenocarcinoma
    Radiotherapy for Pancreatic Adenocarcinoma: Recent Developments and Advances on the Horizon
    Cytotoxic Chemotherapy in Advanced Pancreatic Cancer
    PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma
    Genetics of Pancreatic Neuroendocrine Tumors
    Palliative and Supportive Care for Individuals with Pancreatic Adenocarcinoma
Komentarze (0)